Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 75
Number of items: 75
  • Open Access
    Robinson, E. J., Aguiar, S., Smidt, M. P., & van der Heide, L. P. (2019). MCL1 as a Therapeutic Target in Parkinson's Disease? Trends in Molecular Medicine, 25(12), 1056-1065. https://doi.org/10.1016/j.molmed.2019.08.009
  • Open Access
    van Heesbeen, H. J., & Smidt, M. P. (2019). Entanglement of Genetics and Epigenetics in Parkinson's Disease. Frontiers in Neuroscience, 13, Article 277. https://doi.org/10.3389/fnins.2019.00277
  • Open Access
    Wever, I., Wagemans, C. M. R. J., & Smidt, M. P. (2019). EZH2 Is Essential for Fate Determination in the Mammalian Isthmic Area. Frontiers in Molecular Neuroscience, 12, Article 76. https://doi.org/10.3389/fnmol.2019.00076
  • Open Access
    Cardozo Pinto, D. F., Yang, H., Pollak Dorocic, I., de Jong, J. W., Han, V. J., Peck, J. R., Zhu, Y., Liu, C., Beier, K. T., Smidt, M. P., & Lammel, S. (2019). Characterization of transgenic mouse models targeting neuromodulatory systems reveals organizational principles of the dorsal raphe. Nature Communications, 10, Article 4633. https://doi.org/10.1038/s41467-019-12392-2
  • Open Access
    Wever, I. (2018). Defining mesodiencephalic dopaminergic neurons: Identifying different levels of transcriptional control. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Mesman, S., Krüse, S. J., & Smidt, M. P. (2018). Expression analyzes of early factors in midbrain differentiation programs. Gene expression patterns : GEP, 27, 8-15. https://doi.org/10.1016/j.gep.2017.09.001
  • Open Access
    De Gregorio, R., Pulcrano, S., De Sanctis, C., Volpicelli, F., Guatteo, E., von Oerthel, L., Latagliata, E. C., Esposito, R., Piscitelli, R. M., Perrone-Capano, C., Costa, V., Greco, D., Puglisi-Allegra, S., Smidt, M. P., di Porzio, U., Caiazzo, M., Mercuri, N. B., Li, M., & Bellenchi, G. C. (2018). miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation. Stem Cell Reports, 10(4), 1237-1250. https://doi.org/10.1016/j.stemcr.2018.02.006
  • Open Access
    Robinson, E. J., Aguiar, S. P., Kouwenhoven, W. M., Starmans, D. S., von Oerthel, L., Smidt, M. P., & van der Heide, L. P. (2018). Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1. Cell death discovery, 4, Article 107. https://doi.org/10.1038/s41420-018-0125-7
  • Open Access
    Oliveira, M. A. P., Balling, R., Smidt, M. P., & Fleming, R. M. T. (2017). Embryonic development of selectively vulnerable neurons in Parkinson's disease. NPJ Parkinson's disease, 3, Article 21. https://doi.org/10.1038/s41531-017-0022-4
  • Open Access
    Kouwenhoven, W. M., von Oerthel, L., & Smidt, M. P. (2017). Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool. PLoS ONE, 12(8), Article e0182421. https://doi.org/10.1371/journal.pone.0182421
Page 4 of 8